Another Phase 3 Trial Failure to Develop an Alzheimer’s Drug Shows Why Virgin Coconut Oil is Needed to Prevent Dementia

After more than a decade of failed drug trials and $billions lost in research to try and bring an Alzheimer's drug to market, maybe the pharmaceutical industry is finally ready to admit that they don't really understand what causes Alzheimer's disease. It was announced earlier this week that Roche had failed for the second time to develop a successful Alzheimer's drug. I have been reporting on the failure of Big Pharma to produce an Alzheimer's drug for over a decade now, along with publishing numerous testimonies of how many people have reversed the effects of Alzheimer's and dementia by using Virgin Coconut Oil in their diet, especially if it is part of an overall ketogenic diet which emphasizes healthy high fats, moderate levels of protein, and small amounts of carbohydrates. There is strong evidence that one of the main contributing factors for Alzheimer’s Disease is a diet too low in fats and excessive pharmaceutical drugs. The low-fat dietary advice, and the demonization of cholesterol, has led to poor health and the development of worthless and harmful statin drugs. The data and evidence on the health benefits of coconut oil and the ketogenic diet are overwhelming today, not only for Alzheimer’s Disease, but for a whole host of other diseases as well. I have also written a booklet that not only covers the research and testimonials on how Virgin Coconut Oil has helped so many people with Alzheimer's and dementia, but also includes dietary advice on how to include coconut oil into one's diet and other tips on Holistic Geriatric Care. I am offering this booklet to the public for free....

Big Pharma’s Continued Failure to Develop an Effective Alzheimer’s Drug: Are Alzheimer’s Vaccines Next?

Coconut oil and the high-fact ketogenic diet have proven effective and safe at treating dementia, Parkinson’s disease, and Alzheimer’s. Meanwhile, the pharmaceutical industry’s continued effort at finding drugs to ameliorate Alzheimer’s and Parkinson’s have been a complete failure. There’s too much potential profit in the baby-boomer-turning-seniors market for them to stop; Big Pharma’s boom with cholesterol-lowering statin drugs proved that. There are still way too many who have put their faith in modern mainstream medicine, especially among baby boomers. The next blockbuster drug revenue with Alzheimer’s and Parkinson’s may be with a new Alzheimer vaccine, since vaccines introduced into the market do not need to be effective, and drug companies cannot be sued for any damages resulting from vaccines.

Study: High Amounts of Aluminum in Brains of Alzheimer’s Patients

There have been unconfirmed suspicions that aluminum toxicity is at least a factor for dementia and Alzheimer’s disease. There seems to be no doubt that aluminum is a neurotoxin, but whether there is an aluminum link to Alzheimer’s and other forms of dementia, has not been fully explored just recently. A new study, “Aluminium [British spelling] in brain tissue in familial Alzheimer’s disease” does just that. A pathological brain study of deceased individuals whose bodies were donated by family members. It was conducted in King’s College of London and Keele University of Staffordshire, UK, and published December 2016 in the Journal of Trace Elements in Medicine and Biology. The study’s conclusion: "Aluminium is neurotoxic and the concentrations of aluminium found in these familial AD brains are unlikely to be benign and indeed are highly likely to have contributed to both the onset and the aggressive nature of any ongoing AD in these individuals. These data lend support to the recent conclusion that brain aluminium will contribute towards all forms of AD under certain conditions."